Hajhashemy Z, Golpour-Hamedani S, Eshaghian N, Sadeghi O, Khorvash F, Askari G
Front Nutr. 2024; 11:1433390.
PMID: 39539367
PMC: 11557489.
DOI: 10.3389/fnut.2024.1433390.
Nematgorgani S, Razeghi-Jahromi S, Jafari E, Togha M, Rafiee P, Ghorbani Z
Curr J Neurol. 2023; 21(2):105-118.
PMID: 38011468
PMC: 9860208.
DOI: 10.18502/cjn.v21i2.10494.
Sampaio A, Dalli J, Brancaleone V, DAcquisto F, Perretti M, Wheatley C
Mediators Inflamm. 2013; 2013:741804.
PMID: 23781123
PMC: 3679756.
DOI: 10.1155/2013/741804.
Yuill K, Yarova P, Kemp-Harper B, Garland C, Dora K
Antioxid Redox Signal. 2010; 14(9):1625-35.
PMID: 20615121
PMC: 3070002.
DOI: 10.1089/ars.2010.3279.
Ouardouz M, Coderre E, Basak A, Chen A, Zamponi G, Hameed S
Ann Neurol. 2009; 65(2):151-9.
PMID: 19224535
PMC: 2902553.
DOI: 10.1002/ana.21533.
The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS.
Wheatley C
J Nutr Environ Med. 2008; 16(3-4):181-211.
PMID: 18836533
PMC: 2556189.
DOI: 10.1080/10520290701791839.
A simple, convenient method to synthesize cobalamins: synthesis of homocysteinylcobalamin, N-acetylcysteinylcobalamin, 2-N-acetylamino-2-carbomethoxyethanethiolatocobalamin, sulfitocobalamin and nitrocobalamin.
Suarez-Moreira E, Hannibal L, Smith C, Chavez R, Jacobsen D, Brasch N
Dalton Trans. 2006; (44):5269-77.
PMID: 17088966
PMC: 2754772.
DOI: 10.1039/b610158e.
NO and the vasculature: where does it come from and what does it do?.
Andrews K, Triggle C, Ellis A
Heart Fail Rev. 2002; 7(4):423-45.
PMID: 12379826
DOI: 10.1023/a:1020702215520.
NO as a signalling molecule in the nervous system.
Esplugues J
Br J Pharmacol. 2002; 135(5):1079-95.
PMID: 11877313
PMC: 1573233.
DOI: 10.1038/sj.bjp.0704569.
Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt.
Ellis A, Lu H, Li C, Rand M
Br J Pharmacol. 2001; 134(3):521-8.
PMID: 11588105
PMC: 1572981.
DOI: 10.1038/sj.bjp.0704287.
Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion.
Wanstall J, Jeffery T, Gambino A, Lovren F, Triggle C
Br J Pharmacol. 2001; 134(3):463-72.
PMID: 11588100
PMC: 1572971.
DOI: 10.1038/sj.bjp.0704269.
Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta.
Ellis A, Li C, Rand M
Br J Pharmacol. 2000; 129(2):315-22.
PMID: 10694238
PMC: 1571842.
DOI: 10.1038/sj.bjp.0703058.
Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.
Li C, Karagiannis J, Rand M
Br J Pharmacol. 1999; 127(4):826-34.
PMID: 10433488
PMC: 1566077.
DOI: 10.1038/sj.bjp.0702540.
Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles.
Li C, Rand M
Br J Pharmacol. 1999; 127(1):172-6.
PMID: 10369470
PMC: 1565983.
DOI: 10.1038/sj.bjp.0702496.
Effects of pyrogallol, hydroquinone and duroquinone on responses to nitrergic nerve stimulation and NO in the rat anococcygeus muscle.
La M, Rand M
Br J Pharmacol. 1999; 126(1):342-8.
PMID: 10051154
PMC: 1565785.
DOI: 10.1038/sj.bjp.0702277.
An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse.
Gocmen C, Ucar P, Singirik E, Dikmen A, Baysal F
Urol Res. 1997; 25(4):269-75.
PMID: 9286036
DOI: 10.1007/BF00942097.
Antioxidant protection of NO-induced relaxations of the mouse anococcygeus against inhibition by superoxide anions, hydroquinone and carboxy-PTIO.
Lilley E, Gibson A
Br J Pharmacol. 1996; 119(2):432-8.
PMID: 8886431
PMC: 1915868.
DOI: 10.1111/j.1476-5381.1996.tb16004.x.
Influence of superoxide dismutase inhibition on the discrimination between NO and the nitrergic neurotransmitter in the rat gastric fundus.
Lefebvre R
Br J Pharmacol. 1996; 118(8):2171-7.
PMID: 8864558
PMC: 1909907.
DOI: 10.1111/j.1476-5381.1996.tb15659.x.
Comparison of the effects of hydroxocobalamin and oxyhaemoglobin on responses to NO, EDRF and the nitrergic transmitter.
La M, Li C, Rand M
Br J Pharmacol. 1996; 117(5):805-10.
PMID: 8851494
PMC: 1909394.
DOI: 10.1111/j.1476-5381.1996.tb15264.x.
Inhibition of NO-medicate responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450.
Li C, Rand M
Br J Pharmacol. 1996; 118(1):57-62.
PMID: 8733576
PMC: 1909496.
DOI: 10.1111/j.1476-5381.1996.tb15366.x.